Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
Resource Type
Article
Authors
Pande, Ira ; Tang, Ting Seng ; Tran, Gui ; Layton, Alison ; Price, Elizabeth ; Whittam, Lindsay ; Venkatachalam, Srinivasan ; Huws, Gwenan ; Pratt, Arthur ; Reynolds, Nick J ; Youngstein, Taryn ; Walsh, David A ; Joseph, Theresa ; Mathew, Rengi ; Oikonomou, Stamatios ; Gwynne, Catherine ; Crowder, Rory ; Saravanan, Vadivelu ; Mustafa, Alaa ; Tacu, Cristina ; George, Emmanuel ; Batty, Thomas ; Soni, Anushka ; Horton, Sarah ; Gaffney, Karl ; Gullick, Nicola ; Lapin, Agnieszka ; Bingham, Sarah ; Madan, Ayesha ; Holroyd, Chris ; Lwin, May ; Khalid, Salema ; Green, Mike ; Hunt, Laura ; Alcorn, Nicola ; Ellis, Rob ; Hider, Samantha ; Hassan, Ala ; Douglas, Karen ; Ho, Gen Nen ; Levasseur, Kirsty ; Pradeep, John ; Rhys-Dillon, Ceril ; Jones, Catrin ; Abhishek, Abhishek ; Peckham, Nicholas ; Pade, Corinna ; Gibbons, Joseph M ; Cureton, Lucy ; Francis, Anne ; Barber, Vicki ; Williams, Jennifer A E ; Appelbe, Duncan ; Eldridge, Lucy ; Julier, Patrick ; Altmann, Daniel M ; Bluett, James ; Brooks, Tim ; Coates, Laura C ; Rombach, Ines ; Semper, Amanda ; Otter, Ashley ; Valdes, Ana M ; Nguyen-Van-Tam, Jonathan S ; Williams, Hywel C ; Boyton, Rosemary J ; McKnight, Áine ; Cook, Jonathan A
Source
In The Lancet Rheumatology February 2024 6(2):e92-e104
Subject
Primary Research Articles
Language
ISSN
2665-9913